Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
22.5M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
3.57M
-
Shares change
-
+366K
-
Total reported value, excl. options
-
$2.96M
-
Value change
-
+$299K
-
Number of buys
-
13
-
Number of sells
-
-9
-
Price
-
$0.83
Significant Holders of iBio, Inc. - Common Stock, $0.001 par value per share (IBIO) as of Q3 2025
35 filings reported holding IBIO - iBio, Inc. - Common Stock, $0.001 par value per share as of Q3 2025.
iBio, Inc. - Common Stock, $0.001 par value per share (IBIO) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.57M shares
of 22.5M outstanding shares and own 15.86% of the company stock.
Largest 10 shareholders include Lynx1 Capital Management LP (1.06M shares), Ikarian Capital, LLC (617K shares), AMERIPRISE FINANCIAL INC (482K shares), Opaleye Management Inc. (375K shares), VANGUARD GROUP INC (274K shares), BOOTHBAY FUND MANAGEMENT, LLC (177K shares), GEODE CAPITAL MANAGEMENT, LLC (151K shares), CITADEL ADVISORS LLC (132K shares), TWO SIGMA SECURITIES, LLC (45.1K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (44.5K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.